OPTIMIZATION OF TREATMENT OF PATIENTS WITH ACROMEGALY: INCREASE THE INTERVAL BETWEEN INJECTIONS OF LANREOTIDE


M.B. Antsiferov (1), V.S. Pronin (2)

(1) SBHCI "Endocrinological Dispensary of the Moscow Healthcare Department"; (2) SBEI HPE "First Moscow State Medical University n.a. I.M. Sechenov" of RMPH, Moscow
The article discusses various schemes of transfer of patients receiving octreotide, on lanreotide on (Somatulin® Autogel®) in order to optimize therapy by increasing the interval between injections. The results of the last large study in this area, and own author’s data are presented. Increase of the interval between injections of lanreotide while maintaining the therapeutic effect allows to significantly simplify the regimen of injections and improve patients' adherence to therapy.

About the Autors


M.B.Antsiferov – MD, Prof., Chief Physician of the Endocrinological Dispensary of the Moscow Healthcare Department
V.S.Pronin – MD, Prof. at the Department of Endocrinology SBEI HPE First MSMU n.a. I.M. Sechenov


Similar Articles


Бионика Медиа